Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

RNA Vaccine Shows Promise with Infant Viral Diseases

A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients. . . . → Read More: RNA Vaccine Shows Promise with Infant Viral Diseases

Gut Tissue From Stem Cells Simulated on Organ Chips

Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Engineered Virus Shows Promise in Some Brain Tumors

A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success. . . . → Read More: Engineered Virus Shows Promise in Some Brain Tumors

Report: 19 New Precision Medicines Approved in 2017

A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals. . . . → Read More: Report: 19 New Precision Medicines Approved in 2017

Microsoft Providing A.I. for Big Data Cancer Research

Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp. . . . → Read More: Microsoft Providing A.I. for Big Data Cancer Research

Grants Made to Commercialize Bone, Cancer Research

A program supporting research with commercial potential awarded grants to scientists studying stem cells for bone grafts, treatments for melanoma, and protein therapies for cancer that change gene expression patterns. . . . → Read More: Grants Made to Commercialize Bone, Cancer Research

Energy Dept Grant Funding Poplar Tree Rust Study

A university-government biotechnology lab is studying the genomics of leaf rust, a fungus afflicting poplar trees, an emerging biofuel crop, with the goal of engineering resistance to the pathogen. . . . → Read More: Energy Dept Grant Funding Poplar Tree Rust Study

Institute Using Software to Boost Results Reproducibility

A genomics research lab in the U.K. is adding software to automate data collection that its developer says can improve the productivity of scientists and reproducibility of their findings. . . . → Read More: Institute Using Software to Boost Results Reproducibility